IUS Publications

E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M. M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, vol. 13, 2022.

E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, 2022.

M. Karamehmedović, Šehić, K., Dammann, B., Suljagic, M., and Karamehmedović, E., “Autoencoder-aided measurement of concentration from a single line of speckle”, Optics Express, vol. 27812381370541484395838384998245185982014129, no. 20, p. 29098, 2019.

U. Glamoclija and Suljagic, M., “Prirodni Kinoni i Analozi Kinona u Tretmanu Tumora”, 3rd Congress of Pharmacists with International Participation, vol. 18. Journal of Pharmaceutical Society of Federation of Bosnia and Herzegovina, Sarajevo, pp. 51-61, 2015.

U. Glamoclija and Suljagic, M., “Effects of metformin and thymoquinone on survival of leukemic cells”, HDIR-3. European Association for Cancer Research, Zagreb, 2014.

D. Efremov and Suljagic, M., “Loss of PHLPP1 tumor suppressor enhances Bcr-induced pro-survival signaling in chronic lymphocytic leukemia”, Period Biol, 2012.

N. Kelesoglu, Daria Ler, Efremov, D., and Suljagic, M., “LOSS OF PHLPP1 TUMOR SUPPRESSOR ENHANCES BCR-INDUCED PRO-SURVIVAL SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA ”, PERIODICUM BIOLOGORUM, vol. Vol 114, no. s1 p76, 2012.

N. Kelesoglu, Suljagic, M., and Efremov, D., “Regulation And Consequences Of The Loss Of PHLPP1 Tumor Suppressor In Chronic Lymphocytic Leukemia B Cells”, in 11th CROATIAN BIOLOGICAL CONGRESS with International Participation, Sibenik.